Skip to content

Oxygen saturation endoscopic imaging to assess bowel perfusion: a pilot study

Oxygen saturation endoscopic imaging to assess bowel perfusion: a pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs032210075
Enrollment
30
Registered
2021-05-10
Start date
2021-06-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary rectal cancer

Interventions

in surgery,1st postoperative day, 2nd postoperative day, 3rd postoperative day, 4th postoperative day, 5th post operative day, 6th postoperative day, 7th postoperative day and 28th postoperative day o

Sponsors

Ito Masaaki
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Primary rectal cancer located within 12cm from the anal verge(with or without preoperativetreatment) 2)Histologically proven rectal adenocarcinoma orrectal neuroendocrine tumor 3)Planning elective surgery with excision and anastomosis 4)Age>=20 5)According to the clinical test results within 30 days before registration, the following organ functions are satisfied. WBC>3,000mm^3 Hb>8.0g/dL PLT>100,000mm^3 T-bil<2.0mg/dL AST(GOT)<100U/L ALT(GPT)<100U/L Cr<1.5mg/dL 6)Performance Status ECOG:0 or 1 7)The consent in writing has obtained *1 Regardless of open surgery/laparoscopic surgery *2 Regardless of the reconstructive method *3 Regardless of clinical stage *4 Regardless of the degree of surgical cure *5 With or without comorbidities *6 Cases enrolled in other clinical trials are also acceptable

Exclusion criteria

Exclusion criteria: 1) Emergency surgery is needed 2) Judged inappropriate for this trial

Design outcomes

Primary

MeasureTime frame
StO2 in the perfused area at the boundary betwee n the perfused area and the ischemic area determi ned by intraoperative blood flow evaluation by IC G fluorescence

Secondary

MeasureTime frame
Slope of StO2 curve at the boundary between perf used area and ischemic area judged by intraopera tive blood flow evaluation by ICG fluorescence method Distance between perfused area and ischemic are a judged by intraoperative blood flow evaluation b y OXEI and ICG fluorescence method StO2 in intraoperative and postoperative evaluatio n using OXEI Hemoglobin index in intraoperative and postopera tive evaluation using OXEI Test equipment failure rate Rate of adverse events of Grade 3 or higher and G rade 4 or higher caused by test equipment Incidence of suture failure

Contacts

Public ContactMasaaki Ito

National Cancer Center Hospital East

maito@east.ncc.go.jp+81-4-7133-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026